- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Medtronic to infuse Rs 1200 crore to develop Hyderabad RnD facility
Making the announcement through a virtual meeting, Omar Ishrak said "Medtronics investment in India is a testament to our commitment to the region and we are proud to be collaborating with the Government of Telangana on this major investment in the country. The expansion of MEIC will help us serve the Medtronic Mission to use medical technology to alleviate pain, restore health and extend life for patients around the world, which is also aligned with the government's vision to improve access to healthcare for patients in India."
New Delhi: Medtronic plc, a global leader in medical technology, has decided to invest Rs 1,200 crore in scaling up and expanding it's Research and Development center here into a state-of-the-art engineering and innovation center.
Medtronic Engineering and Innovation Center (MEIC) will be the largest global R&D center outside of the United States for Medtronic and the proposed investment, planned over 5 years, will provide a boost to Telangana's MedTech plans and cement the city's position as the Medical Devices hub in India, an official release said here on Tuesday.
During his visit to the United States in 2016, Minister for Industries and IT KT Rama Rao and his team of officials had a meeting with Omar Ishrak, Executive Chairman and Chairman of the Board, Medtronic and both have been in discussion for the last two years regarding the modalities of investment, the release said.
Also Read: Medtronic Sees Hit To Revenue As Hospitals Delay Elective Procedures
Making the announcement through a virtual meeting, Omar Ishrak said "Medtronics investment in India is a testament to our commitment to the region and we are proud to be collaborating with the Government of Telangana on this major investment in the country. The expansion of MEIC will help us serve the Medtronic Mission to use medical technology to alleviate pain, restore health and extend life for patients around the world, which is also aligned with the government's vision to improve access to healthcare for patients in India."
Rama Rao said the state government is committed to the growth of med-tech in the state and hoped that the partnership with Medtronic will play a pivotal one. "We are delighted that Medtronic has chosen Hyderabad as its largest R&D base outside the U.S. and intends to create about 1,000 jobs in the next few years. It is indeed a great honor for the city to host this center and it is a testimony to Hyderabad's growing prowess in the medical devices sector," the minister said.
Also Read: Medtronic MiniMed 670G Insulin Pump Allows 'Excellent' Blood Sugar Control
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751